Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2025-12-25 @ 12:56 AM
NCT ID:
NCT00518193
Eligibility Criteria:
Inclusion Criteria:
* More than 18 years old.
* Epidermoïde carcinoma or adenocarcinoma of the cervix, hystologic proved
* Patientes in a late stage or with progresive desease.
* One mesurable lesion in irradiated zone.
* Patient who have already treated radio-chimiothérapy with platine should have a 6 month free interval.
* Index status of ECOG (" Eastern Cooperative Oncology Group ")less than 2.
* Good biologicals and hematologicals fonctions:
* Neutrophiles noless than 1,5.109/L.
* Platelets nolss than 100.109/L.
* Total bilirubin no more than 1,5 time the normal superior range.
* Transaminases no mote than 3 x Time NSR
* Creatinine clairance Cockroft) more than 50 mL/min .
* Inform consent signed.
Exclusion Criteria:
* Previous cytotoxic traitement exept radio-chaemiotherapy of the pelvis cerebrals metastasis.
* Other cancer in the last 5 years exept treated BCC.
* Dermatologic desease.
* Crohn desease or Hemorragic rectal-Colitis.
* Neuropathy.
* Psychologic disorder.
* Social troubles.
* Pregnant women.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00518193
Study Brief:
Protocol Section:
NCT00518193